UBS Group’s NeuroSense Therapeutics NRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.05K | Sell |
1,611
-664
| -29% | -$1.26K | ﹤0.01% | 8068 |
|
|
2025
Q1 | $2.12K | Buy |
+2,275
| New | +$2.12K | ﹤0.01% | 8068 |
|
|
2024
Q2 | – | Sell |
-11,928
| Closed | -$21.7K | – | 8639 |
|
|
2024
Q1 | $21.7K | Buy |
11,928
+6,432
| +117% | +$11.7K | ﹤0.01% | 5722 |
|
|
2023
Q4 | $4.31K | Sell |
5,496
-4,169
| -43% | -$3.27K | ﹤0.01% | 6668 |
|
|
2023
Q3 | $6.86K | Buy |
+9,665
| New | +$6.86K | ﹤0.01% | 6127 |
|
|
2023
Q2 | – | Sell |
-4,762
| Closed | -$8.19K | – | 8216 |
|
|
2023
Q1 | $8.19K | Buy |
4,762
+697
| +17% | +$1.2K | ﹤0.01% | 6652 |
|
|
2022
Q4 | $4.96K | Buy |
4,065
+2,238
| +122% | +$2.73K | ﹤0.01% | 8040 |
|
|
2022
Q3 | $3K | Sell |
1,827
-11,601
| -86% | -$19K | ﹤0.01% | 8455 |
|
|
2022
Q2 | $45K | Buy |
13,428
+11,544
| +613% | +$38.7K | ﹤0.01% | 4990 |
|
|
2022
Q1 | $7K | Sell |
1,884
-6,134
| -77% | -$22.8K | ﹤0.01% | 7772 |
|
|
2021
Q4 | $20K | Buy |
+8,018
| New | +$20K | ﹤0.01% | 6727 |
|